Edwards Lifesciences Corporation announced that Donald E. Bobo, Jr., Corporate Vice President of Strategy and Corporate Development, will retire from the company by mid-year 2027. The board has initiated a search for his successor, with duties expected to transition during 2027. Mr. Bobo will remain as a consultant through the end of 2027. Edwards Lifesciences Corporation operates in the medical device industry, specializing in products and services for patients with structural heart disease and critical care monitoring.
